Obesity, inflammation, and periodontal disease

Journal of Dental Research

Volumn 86, Issue 5, 2007, Pages 400-409

  Pischon, N ^a   Heng, N ^a   Bernimoulin, J P ^a   Kleber, B M ^a   Willich, S N ^a   Pischon, T ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Adipose tissue; Inflammation; Obesity; Periodontal disease

Indexed keywords

AUTACOID; CYTOKINE;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIODONTITIS; REVIEW; RISK FACTOR;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; METABOLIC SYNDROME X; OBESITY; PERIODONTITIS; RISK FACTORS;

EID: 34249310976     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600503     Document Type: Review

References (123)

1. Al-Zahrani MS, Bissada NF, Borawskit EA (2003). Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74:610-615.
2. Al-Zahrani MS, Borawski EA, Bissada NF (2005a). Periodontitis and three health-enhancing behaviors: maintaining normal weight, engaging in recommended level of exercise, and consuming a high-quality diet. J Periodontol 76:1362-1366.
3. Al-Zahrani MS, Borawski EA, Bissada NF (2005b). Increased physical activity reduces prevalence of periodontitis. J Dent 33:703-710.
4. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. (2002). Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105:2893-2898.
5. Armstrong M (1998). Obesity as an intrinsic factor affecting wound healing. J Wound Care 7:220-221.
6. Beck JD, Offenbacher S (2005). Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76(11 Suppl):2089-2100.
7. Beck J, Garcia R, Heiss G, Vokonas P, Offenbacher S (1996). Periodontal disease and cardiovascular disease. J Periodontol 67(10 Suppl):1123-1137.
8. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R (1998). Periodontitis: a risk for coronary heart disease? Ann Periodontol 3:127-141.
9. Berg AH, Scherer PE (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949.
10. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953.
11. Berg AH, Combs TP, Scherer PE (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89.
12. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV (2006). Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J Clin Endocrinol Metab 91:64-68.
13. Caccamese SM, Kolodner K, Wright SM (2002). Comparing patient and physician perception of weight status with body mass index. Am J Med 112:662-666.
14. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999). Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105.
15. Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003). Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-2450.
16. Choo V (2002). WHO reassesses appropriate body-mass index for Asian populations. Lancet 360(9328):235.
17. Cleator J, Richman E, Leong K.S, Mawdsley L, White S, Wilding J (2002). Obesity: under-diagnosed and under-treated in hospital outpatient departments. Int J Obes Relat Metab Disord 26:581-584.
18. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report (1998). NIH Publication No. 98-4083, September. National Institutes of Health. http://www.nhlbi.gov/ guidelines/obesity/ob_gdlns.pdf
19. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, et al. (2002). Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415.
20. Curtis JP, Seller JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. (2005). The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55-61.
21. Dalla Vecchia CF, Susin C, Rösing CK, Oppermann RV, Albandar JM (2005). Overweight and obesity as risk indicators for periodontitis in adults. J Periodontol 76:1721-1728.
22. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. TV Engl J Med 350:1387-1397.
23. Dietrich T, Garcia RI (2005). Associations between periodontal disease and systemic disease: evaluating the strength of the evidence. J Periodontol 76(11 Suppl):2175-2184.
24. Ducy P, Schinke T, Karsenty G (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501-1504.
25. Eckel RH, Grundy SM, Zimmet PZ (2005). The metabolic syndrome. Lancet 365(9468):1415-1428.
26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001). J Am Med Assoc 285:2486-2497.
27. Expert Panel (1998). Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158:1855-1867.
28. Faggioni R, Fantuzzi G, Fuller J, Dinarello CA, Feingold K, Grunfeld C (1998). Il-l beta mediates leptin induction during inflammation. Am J Physiol 274:204-208.
29. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. (1999). Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884.
30. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, el al. (2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581-1586.
31. Flegal KM (2006). Excess deaths associated with obesity: cause and effect. Int J Obes (Land) 30:1171-1172.
32. Flegal KM, Graubard BI, Williamson DF, Gail MH (2005). Excess deaths associated with underweight, overweight and obesity. J Am Med Assoc 293:1861-1867.
33. Ford ES, Giles WH, Dietz WH (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 287:356-359.
34. Friedman JM (1998). Leptin, leptin receptors, and the control of body weight. Nutr Rev 56(2 Pt 2):s38-s46; discussion s54-s75.
35. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307(5708):426-430.
36. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005). A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 76(11 Suppl):2075-2084.
37. Gomez-Ambrosi J, Fruhbeck G (2001). Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Ann Intern Med 135:306-307.
38. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. (2005). Secular trends in cardiovascular disease risk factors according to body mass index in US adults. J Am Med Assoc 293:1868-1874.
39. Grossi SG, Genco RJ (1998). Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 3:51-61.
40. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, et al. (1996). Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97:2152-2157.
41. Haslam DW, James WP (2005). Obesity. Lancet 366(9492):1197-1209.
42. Heymsfield SB, Allison DB, Wang Z, Baumgartner RN, Ross R (1998). Evaluation of total and regional body composition. In: Handbook of obesity. Bray GA, Bouchard C, James WPT, editors. New York: Marcel Dekker, pp. 41-77.
43. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055.
44. Hotamisligil GS (1999). The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245:621-625.
45. Hotamisligil GS (2000). Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 24(Suppl 4):S23-S27.
46. International Diabetes Federation (2005). The IDF consensus worldwide definition of the metabolic syndrome. 1st International Congress on "Prediabetes" & the Metabolic Syndrome, Berlin.
47. Johnson RB, Serio FG (2001). Leptin within healthy and diseased human gingiva. J Periodontol 72:1254-1257.
48. Karjalainen S, Vanhamaki M, Kanto D, Kossi L, Sewon L, Salo M (2002). Long-term physical inactivity and oral health in Finnish adults with intellectual disability. Acta Odontol Scand 60:50-55.
49. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415-419.
50. Kempers KG, Foote JW, DiFlorio-Brennan T (2000). Obesity: prevalence and considerations in oral and maxillofacial surgery. J Oral Maxillofac Surg 58:137-143.
51. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. (2002). Obesity and the risk of heart failure. N Engl J Med 347:305-313.
52. Kennedy GC (1953). The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Land B Biol Sci 140:578-596.
53. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751.
54. Kershaw EE, Flier JS (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556.
55. Kolanowski J (1999). Obesity and hypertension: from pathophysiology to treatment. Int J Obes Relat Metab Disord 23(Suppl 1):42-46.
56. Koletsky S (1973). Obese spontaneously hypertensive rats - a model for study of atherosclerosis. Exp Mol Pathol 19:53-60.
57. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. (2002). Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866.
58. Libby P (2002). Inflammation in atherosclerosis. Nature 420:868-874.
59. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58.
60. Linne Y, Rossner S (1998). What is "obesity" - an analysis of referral letters to an obesity unit. Jnt J Obes Relat Metab Disord 22:1231-1233.
61. Loos BG (2005). Systemic markers of inflammation in periodontitis. J Periodontol 76(11 Suppl):2106-2115.
62. Loos BG, Mutter J, Varoufaki A, Bulthuis H, Craandijk J, Huffels RAM, et al. (1998). Levels of C-reactive protein in periodontitis patients and healthy controls (abstract). J Dent Res 77(Spec Iss B):666.
63. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737.
64. Margetic S, Gazzola C, Pegg GG, Hill A (2002). Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407-1433.
65. Mattila KJ, Pussinen PJ, Paju S (2005). Dental infections and cardiovascular diseases: a review. J Periodontol 76(11 Suppl):2085-2088.
66. Merchant AT, Pitiphat W, Rimm EB, Joshipura K (2003). Increased physical activity decreases periodontitis risk in men. Eur J Epidemiol 18:891-898.
67. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. (2003). Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 289:76-79.
68. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004). Actual causes of death in the United States, 2000. J Am Med Assoc 291:1238-1245.
69. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999). The disease burden associated with overweight and obesity. J Am Med Assoc 282:1523-1529.
70. Nagaev I, Smith U (2001). Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564.
71. Nishida N, Tanaka M, Hayashi N, Nagata H, Takeshita T, Nakayama K, et al. (2005). Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol 76:923-928.
72. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y (2003). Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol 74:97-102.
73. Offenbacher S (1996). Periodontal diseases: pathogenesis. Ann Periodontol 1:821-878.
74. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006). Prevalence of overweight and obesity in the United States, 1999-2004. J Am Med Assoc 295:1549-1555.
75. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, et al. (2005). Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295-301.
76. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301.
77. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063.
78. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity (2000). Arch Intern Med 160:898-904.
79. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. (2004). Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599-2610.
80. Perlstein MI, Bissada NF (1977). Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol 43:707-719.
81. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB (2003). Leisure-time physical activity and reduced plasma levels of obesityrelated inflammatory markers. Obes Res 11:1055-1064.
82. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB (2004). Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 291:1730-1737.
83. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, et al. (2005). Association of plasma resistin levels with coronary heart disease in women. Obes Res 13:1764-1771.
84. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. (1994). Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-468.
85. Pradhan AD, Ridker PM (2002). Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 23:831-834.
86. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 286:327-334.
87. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, et al (2002). Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 16:1920-1930.
88. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, et al. (2001). Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426-1433.
89. Ridker PM (2002). On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2-4.
90. Rotter V, Nagaev I, Smith U (2003). Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784.
91. Saito T, Shimazaki Y, Sakamoto M (1998). Obesity and periodontitis. N Engl J Med 339:482-483.
92. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Oshima A (2001). Relationship between upper body obesity and periodontitis. J Dent Res 80:1631-1636.
93. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, et al. (2005). Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res 40:346-353.
94. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. (2001). Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199-2202.
95. Seidell JC (2000). Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 83(Suppl l):5-8.
96. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226-228.
97. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. (2001 a). The hormone resistin links obesity to diabetes. Nature 409(6818):307-312.
98. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, et al. (2001b). A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98:502-506.
99. Stumvoll M, Goldstein BJ, van Haeften TW (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365(9467):1333-1346.
100. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (2002). Circulation 106:3143-3421.
101. Thomas T (2003). Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine 70:18-21.
102. Thomas T, Burguera B (2002). Is leptin the link between fat and bone mass? J Bone Miner Res 17:1563-1569.
103. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL (1999). Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation of adipocytes. Endocrinology 140:1630-1638.
104. Thompson D, Wolf AM (2001). The medical-care cost burden of obesity. Obes Rev 2:189-197.
105. Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA (1996). The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 20:63-75.
106. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. (2003). Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736-740.
107. Wajchenberg BL (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738.
108. Wakai K, Kawamura T, Umemura O, Hara Y, Machida J, Anno T, et al. (1999). Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 26:664-672.
109. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB (2005). Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81:555-563.
110. WHO (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Geneva: World Health Organization.
111. WHO/IASO/IOTF (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: Health Communications Australia Pty Limited.
112. Willett WC, Hu FB, Colditz GA, Manson JE (2005). Underweight, overweight, obesity, and excess deaths. J Am Med Assoc 294:551;
113. author reply, J Am Med Assoc 294:552-553.
114. Wilson JA, Clark JJ (2004). Obesity: impediment to postsurgical wound healing. Adv skin wound care 17:426-435.
115. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB (2002). Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867-1872.
116. Wolf HK, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, et al. (1997). Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens 11:733-742.
117. Wood N, Johnson RB, Streckfus CF 2003). Comparison of body composition and periodontal disease using nutritional assessment techniques. Third National Health and Nutrition Examination Survey (NHANES III). J Clin Periodontol 30:321-327.
118. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946.
119. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362.
120. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000). Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209214.
121. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. (2005). Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366:1640-1649.
122. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.
123. Zucker TF, Zucker LM (1962). Hereditary obesity in the rat associated with high serum fat and cholesterol. Proc Soc Exp Biol Med 110:165-171.